Answers are grounded in this paper and cite their sources.
Highlights recent evidence establishing PDE1 as a key regulator of cardiomyocyte physiology and a potential therapeutic target for heart failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Leroy et al. (2018) conducted an editorial in Heart failure. PDE1 inhibitors was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: